Sentiment-Signal
17,4
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 05.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Ap |
| 15.07.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
| 11.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
Stammdaten
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Unternehmen & Branche
| Name | Prime Medicine, Inc. |
|---|---|
| Ticker | PRME |
| CIK | 0001894562 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 636,5 Mio. USD |
| Beta | 2,67 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 4,632,000 | -201,142,000 | -1.35 | 342,733,000 | 120,868,000 |
| 2025-09-30 | 10-Q | 1,225,000 | -50,582,000 | -0.32 | 385,012,000 | 161,821,000 |
| 2025-06-30 | 10-Q | 1,115,000 | -52,591,000 | -0.41 | 279,009,000 | 60,860,000 |
| 2025-03-31 | 10-Q | 1,454,000 | -51,890,000 | -0.40 | 328,163,000 | 106,924,000 |
| 2024-12-31 | 10-K | 2,983,000 | -195,882,000 | -1.65 | 297,508,000 | 153,149,000 |
| 2024-09-30 | 10-Q | 209,000 | -52,518,000 | -0.44 | 332,784,000 | 189,504,000 |
| 2024-06-30 | 10-Q | 0 | -55,327,000 | -0.46 | 259,705,000 | 196,589,000 |
| 2024-03-31 | 10-Q | 591,000 | -45,761,000 | -0.44 | 311,383,000 | 243,766,000 |
| 2023-12-31 | 10-K | 0 | -198,133,000 | -2.18 | 193,851,000 | 133,071,000 |
| 2023-09-30 | 10-Q | 0 | -50,708,000 | -0.55 | 239,145,000 | 193,957,000 |
| 2023-06-30 | 10-Q | 0 | -42,385,000 | -0.47 | 280,865,000 | 240,102,000 |
| 2023-03-31 | 10-Q | 0 | -39,397,000 | -0.44 | 316,946,000 | 278,801,000 |
| 2022-12-31 | 10-K | 0 | -121,821,000 | -4.19 | 360,314,000 | 316,270,000 |
| 2022-09-30 | 10-Q | -29,350,000 | -1.61 | 215,265,000 | -223,096,000 | |
| 2022-06-30 | 10-Q | -29,348,000 | -1.76 | -195,063,000 | ||
| 2022-03-31 | 10-Q | -23,840,000 | -1.58 | -166,943,000 | ||
| 2021-12-31 | 10-K | 0 | -165,367,000 | -14.19 | 301,856,000 | -156,240,000 |
| 2021-09-30 | 10-Q | -16,412,000 | -1.52 | -94,418,000 | ||
| 2021-06-30 | 10-Q | 616,000 | -78,370,000 | |||
| 2021-03-31 | 10-Q | -86,660,000 | -85,310,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-08-01 | GV 2021 GP, L.L.C. | 10% Owner | Open Market Purchase | 1,500,000 | 3.30 | 4,950,000.00 | +153,8% | |
| 2025-08-01 | ARCH Venture Partners XII, LLC | 10% Owner | Open Market Purchase | 3,030,300 | 3.30 | 9,999,990.00 | +310,8% | |
| 2025-08-01 | ARCH Venture Partners X, LLC | 10% Owner | Open Market Purchase | 3,030,300 | 3.30 | 9,999,990.00 | +310,8% | |
| 2025-08-01 | NELSEN ROBERT | Director, 10% Owner | Open Market Purchase | 3,030,300 | 3.30 | 9,999,990.00 | +310,8% | |
| 2025-06-30 | Liu David R. | 10% Owner | Open Market Purchase | 21,000 | 2.52 | 52,829.70 | +1,6% | |
| 2025-06-23 | Liu David R. | 10% Owner | Open Market Purchase | 21,000 | 2.16 | 45,402.00 | +1,4% | |
| 2025-06-16 | Liu David R. | 10% Owner | Open Market Purchase | 21,000 | 1.49 | 31,195.50 | +1,0% | |
| 2025-06-11 | Liu David R. | 10% Owner | Open Market Purchase | 21,000 | 1.60 | 33,589.50 | +1,0% | |
| 2025-05-21 | LEE ANN L. | Officer, Chief Technical Officer | Open Market Purchase | 100,000 | 1.13 | 113,000.00 | +3,5% | |
| 2025-05-21 | Reine Allan | Director, Officer, Chief Executive Officer | Open Market Purchase | 125,000 | 1.18 | 147,150.00 | +4,6% | |
| 2025-05-20 | Brudnick Richard | Officer, Chief Business Officer | Open Market Purchase | 20,000 | 1.19 | 23,790.00 | +0,7% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.